A computed tomography-based radiomics prediction model for BRAF mutation status in colorectal cancer.

purposeThe aim of this study was to develop and validate CT venous phase image-based radiomics to predict BRAF gene mutation status in preoperative colorectal cancer patients.

methodsIn this study, 301 patients with pathologically confirmed colorectal cancer were retrospectively enrolled, comprising 225 from Centre I (73 mutant and 152 wild-type) and 76 from Centre II (36 mutant and 40 wild-type). The Centre I cohort was randomly divided into a training set (n = 158) and an internal validation set (n = 67) in a 7:3 ratio, while Centre II served as an independent external validation set (n = 76). The whole tumor region of interest was segmented, and radiomics characteristics were extracted. To explore whether tumor expansion could improve the performance of the study objectives, the tumor contour was extended by 3 mm in this study. Finally, a t-test, Pearson correlation, and LASSO regression were used to screen out features strongly associated with BRAF mutations. Based on these features, six classifiers-Support Vector Machine (SVM), Decision Tree (DT), Random Forest (RF), Logistic Regression (LR), K-Nearest Neighbors (KNN), and Extreme Gradient Boosting (XGBoost)-were constructed. The model performance and clinical utility were evaluated using receiver operating characteristic (ROC) curves, decision curve analysis, accuracy, sensitivity, and specificity.

resultsGender was an independent predictor of BRAF mutations. The unexpanded RF model, constructed using 11 imaging histologic features, demonstrated the best predictive performance. For the training cohort, it achieved an AUC of 0.814 (95% CI 0.732-0.895), an accuracy of 0.810, and a sensitivity of 0.620. For the internal validation cohort, it achieved an AUC of 0.798 (95% CI 0.690-0.907), an accuracy of 0.761, and a sensitivity of 0.609. For the external validation cohort, it achieved an AUC of 0.737 (95% CI 0.616-0.847), an accuracy of 0.658, and a sensitivity of 0.667.

conclusionsA machine learning model based on CT radiomics can effectively predict BRAF mutations in patients with colorectal cancer. The unexpanded RF model demonstrated optimal predictive performance.